top of page
News, Events and Updates
Search
Jan 12, 2015
Anavex Doses First Alzheimer's Patient in Phase 2a Trial of ANAVEX 2-73 and ANAVEX PLUS
Jan 8, 2015
Anavex Announces Panel Discussion and Presentation at OneMedForum Conference
Jan 6, 2015
Anavex Encouraged by Scientific Data Confirming Sigma-1 Receptor's Beneficial Direct Interaction
Dec 30, 2014
Anavex Announces Fiscal 2014 Fourth Quarter and Year-End Financial Results
Dec 18, 2014
Anavex to Present at Biotech Showcase 2015 in San Francisco
Dec 16, 2014
Enrollment of Alzheimer's Patients in Phase 2a Clinical Trial of ANAVEX 2-73 and ANAVEX PLUS Begins
Dec 12, 2014
Anavex Upgrades to OTCQX Marketplace
Dec 11, 2014
Phase1 Dose Escalation Study to Investigate Safety, Tolerability, and Pharmacokinetics of ANAVEX2-73
Nov 17, 2014
Anavex Announces Positive Phase 1 Data for ANAVEX 2-73, Lead Candidate for Treatment of Alzheimer's
Nov 10, 2014
Anavex to Present Full Phase 1 Clinical Trial Data for ANAVEX 2-73 at CNS Summit 2014 Conference
Nov 6, 2014
Anavex to Present at SeeThruEquity Investor Conference in New York City
35
36
37
38
39
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
